Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Change in Account Payables (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Change in Account Payables readings, the most recent being -$669000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 295.86% to -$669000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 2512.96% increase, with the full-year FY2025 number at $1.4 million, up 2512.96% from a year prior.
  • Change in Account Payables hit -$669000.0 in Q4 2025 for Aligos Therapeutics, down from $752000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.0 million in Q2 2024 to a low of -$4.1 million in Q3 2024.
  • Median Change in Account Payables over the past 5 years was $0.0 (2022), compared with a mean of $32750.0.
  • The widest YoY moves for Change in Account Payables: up 849.16% in 2024, down 1259.67% in 2024.
  • Aligos Therapeutics' Change in Account Payables stood at $399000.0 in 2021, then surged by 352.63% to $1.8 million in 2022, then crashed by 123.42% to -$423000.0 in 2023, then soared by 60.05% to -$169000.0 in 2024, then plummeted by 295.86% to -$669000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$669000.0 (Q4 2025), $752000.0 (Q3 2025), and -$402000.0 (Q2 2025) per Business Quant data.